- ►diabetesjournals.org A Lopez-Bermejo, B Chico-Julia, M Fernandez … - Diabetes, 2006 - Am Diabetes Assoc Visfatin has shown to be increased in type 2 diabetes but to be unrelated to
insulin sensitivity. We hypothesized that visfatin is associated with insulin
secretion in humans. To this aim, a cross-sectional study was conducted in ... Cited by 82 - Related articles - BL Direct - All 5 versions
T Dogru, A Sonmez, I Tasci, E Bozoglu, MI … - Diabetes research and clinical practice, 2007 - Elsevier Visfatin, a new adipokine, facilitates adipogenesis and has insulin-mimetic
properties. We aimed to investigate the plasma visfatin levels in patients with
newly diagnosed and untreated type 2 diabetes mellitus (T2DM) and impaired ... Cited by 77 - Related articles - All 12 versions
K Krzyzanowska, W Krugluger, F Mittermayer … - Clinical Science, 2006 - clinsci.org The recently discovered adipocytokine visfatin has insulin-like properties. It
lowers blood glucose and improves insulin sensitivity; however, clinical data on
visfatin are limited. To evaluate the role of visfatin in GDM (gestational ... Cited by 91 - Related articles - Cached - BL Direct - All 10 versions
WX Jian, TH Luo, YY Gu, HL Zhang, S Zheng, … - Diabetic Medicine, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 45 - Related articles - BL Direct - All 4 versions
- ►endojournals.org C Pagano, C Pilon, M Olivieri, P Mason, R … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Results: Plasma visfatin and its mRNA in SAT were significantly lower in obese
subjects, compared with normal-weight controls. Both circulating visfatin and
SAT visfatin mRNA were negatively correlated with body mass index, whereas ... Cited by 115 - Related articles - BL Direct - All 6 versions
E Esteve, R Casamitjana, W Ricart, JM … - DIABETES, 2006 - Am Diabetes Assoc Visfatin has shown to be increased in type 2 diabetes but to be unrelated to
insulin sensitivity. We hypothesized that visfatin is associated with insulin
secretion in humans. To this aim, a cross-sectional study was conducted in ... Related articles
DG Haider, G Schaller, S Kapiotis, C Maier, A … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis The novel insulin-mimetic adipocytokine visfatin has
been linked to the metabolic syndrome, but its regulation has not been
characterised to date. Since insulin- mimetic actions of visfatin may be ... Cited by 105 - Related articles - BL Direct - All 4 versions
- ►endojournals.org MP Chen, FM Chung, DM Chang, JCR Tsai, HF … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Results: A total of 61 patients with T2DM and 59 sex- and age-matched
nondiabetic subjects were studied. Plasma visfatin was found to be elevated in
patients with T2DM (31.9 ± 31.7 vs. 15.8 ± 16.7 ng/ml, P = 0.002). In ... Cited by 300 - Related articles - BL Direct - All 4 versions
